No black box warning on record for Cardiolite
As of the latest FDA labeling reviewed, Cardiolite (TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cardiolite medicine page for the complete safety profile.